Codiak BioSciences, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY21 | FY20 | FY19 | |
|---|---|---|---|
| Revenue | $22.9M | $2.9M | $388,000 |
| Operating income | −$69.5M | −$90.9M | −$80.2M |
| Net income | −$37.2M | −$91.7M | −$78.0M |
| Total assets | $171.7M | $151.3M | $116.0M |
| Total liabilities | $118.2M | $136.8M | $94.0M |
| Equity | $53.5M | $14.6M | −$192.8M |
| EPS (diluted) | — | — | — |
| Shares out. | 22.0M | 18.8M | 3.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2021- Operating margin
- −303.2%
- Net margin
- −162.0%
- Return on equity
- −69.4%
- Return on assets
- −21.6%
- Return on capital (ROCE)
- −48.1%
- Liabilities / assets
- 68.8%
- Debt / equity
- 2.21×
- Book value / share
- $2.43
- Revenue growth (YoY)
- 686.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2021- Altman Z″ (distress)
- -6.02distress
- Accruals / assets
- 21.5%high accruals
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 29, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeMar 29, 2023
- Bankruptcy or receivership · Costs from exit or disposal · Director / officer change · Other material eventMar 27, 2023
- Results of operationsNov 3, 2022
- Entered a material agreement · Other material eventSep 14, 2022
- Costs from exit or disposal · Other material eventAug 30, 2022
- Results of operationsAug 4, 2022
- Regulation FD disclosureJun 30, 2022
- Other material eventJun 29, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.